Cheminformatic Tools and Databases for Pharmacology

session 74104 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
ZIPRASIDONE

ZIPRASIDONE


ATC N05AE04

NERVOUS SYSTEM
TREATMENT OF BIPOLAR DISORDER
ANTIPSYCHOTIC
DOPAMINE D2 (KI = 4.8 NANOMOLAR) AND D3 (KI = 7.2 NANOMOLAR) ANTAGONISTS
SEROTONIN 5HT2A (KI = 0.4 NANOMOLAR) 5HT2C (KI = 1.3 NANOMOLAR) 5HT1D (KI = 2 NANOMOLAR) ANTAGONISTS
ALPHA 1 ADRENERGIC RECEPTOR (KI = 10 NANOMOLAR) ANTAGONISTS
5HT1A RECEPTOR AGONIST (KI = 3.4 NANOMOLAR)

ORAL INTRAMUSCULAR

Tmax 7 HOUR

F 60 PERCENT

VD 97.5 LITER (65 KILOGRAM)

PPB 99 PERCENT

Cl 29.2 LITER / HOUR (65 KILOGRAM)

HT 7 HOUR

ALPHA 1 ADRENERGIC RECEPTOR
5-HYDROXYTRYPTAMINE 1A RECEPTOR
D(2) DOPAMINE RECEPTOR
5-HYDROXYTRYPTAMINE 2A RECEPTOR
5-HYDROXYTRYPTAMINE 2C RECEPTOR
D(3) DOPAMINE RECEPTOR
5-HYDROXYTRYPTAMINE 1D RECEPTOR

D(2) dopamine receptor UNIPROT P14416 DRD2 -- 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |